However, several studies have shown a higher rate of malignant transformation in IDH-mutated low grade glioma than in wild-type IDH1 tumors, showing that a subset of patients with the IDH1 mutation are characterized as having secondary glioblastoma [24, 25]. This evidence concerns the gene IDH1 and glioma.